15d-PGJ2 Reduced Microglia Activation and Alleviated Neurological Deficit of Ischemic Reperfusion in Diabetic Rat Model
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
15d-PGJ2 Reduced Microglia Activation and Alleviated Neurological Deficit of Ischemic Reperfusion in Diabetic Rat Model
Authors
Keywords
-
Journal
Biomed Research International
Volume 2015, Issue -, Pages 1-7
Publisher
Hindawi Limited
Online
2015-12-31
DOI
10.1155/2015/864509
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regulation of peroxisome proliferator-activated receptors (PPAR) α and -γ of rat brain astrocytes in the course of activation by toll-like receptor agonists
- (2015) Dmitry V. Chistyakov et al. JOURNAL OF NEUROCHEMISTRY
- 15d-Prostaglandin J2 Protects Cortical Neurons Against Oxygen–Glucose Deprivation/Reoxygenation Injury: Involvement of Inhibiting Autophagy Through Upregulation of Bcl-2
- (2014) Haidong Qin et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- 15-Deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) promotes apoptosis of HBx-positive liver cells
- (2014) Siyan Chen et al. CHEMICO-BIOLOGICAL INTERACTIONS
- 15-deoxy-Δ12,14-PGJ2 promotes inflammation and apoptosis in cardiomyocytes via the DP2/MAPK/TNFα axis
- (2014) Chintan N. Koyani et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Targets of vascular protection in acute ischemic stroke differ in type 2 diabetes
- (2013) Aisha I. Kelly-Cobbs et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Dominant negative PPARγ promotes atherosclerosis, vascular dysfunction, and hypertension through distinct effects in endothelium and vascular muscle
- (2013) Christopher J. Pelham et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Neuroprotection for Ischemic Stroke: Moving Past Shortcomings and Identifying Promising Directions
- (2013) Ryan Turner et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Neurodegeneration and Neuroprotection in Diabetic Retinopathy
- (2013) Mohammad Ola et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pioglitazone enhances cholesterol efflux from macrophages by increasing ABCA1/ABCG1 expressions via PPARγ/LXRα pathway: Findings from in vitro and ex vivo studies
- (2011) Hideki Ozasa et al. ATHEROSCLEROSIS
- Vascular smooth muscle cell-derived adiponectin: A paracrine regulator of contractile phenotype
- (2011) Min Ding et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Microglial activation during acute cerebral infarction in the presence of diabetes mellitus
- (2011) Gang Li et al. NEUROLOGICAL SCIENCES
- Vascular Smooth Muscle Cell Peroxisome Proliferator–Activated Receptor-γ Mediates Pioglitazone-Reduced Vascular Lesion Formation
- (2010) Milton Hamblin et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy
- (2009) Parag Aggarwal et al. ADVANCED DRUG DELIVERY REVIEWS
- PPAR-γ agonist rosiglitazone prevents inflammatory periodontal bone loss by inhibiting osteoclastogenesis
- (2009) Márcio Y. Hassumi et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Microglia Protect Neurons against Ischemia by Synthesis of Tumor Necrosis Factor
- (2009) K. L. Lambertsen et al. JOURNAL OF NEUROSCIENCE
- Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) Ligands: Novel Pharmacological Agents in the Treatment of Ischemia Reperfusion Injury
- (2008) Costas Giaginis et al. CURRENT MOLECULAR MEDICINE
- Brain inflammation and adult neurogenesis: The dual role of microglia
- (2008) C.T. Ekdahl et al. NEUROSCIENCE
- Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists
- (2007) Ramya Kapadia Frontiers in Bioscience-Landmark
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started